Clinical Trials Logo

Clinical Trial Summary

Mindfulness-based interventions have gained increasing popularity in recent years as effective treatment for mental illness. Mindfulness is defined as paying attention in a particular way: on purpose, in the present moment, and non-judgmentally: "Being", rather than "Doing". Such mental states can improve emotional regulation through frontal cortex inhibition of otherwise dysregulated subcortical emotion-related circuits. Formal mindfulness approaches such as mindfulness-based cognitive therapy (MBCT) and mindfulness-based stress reduction, have been highly effective in a broad range of psychiatric disorders.

Mindfulness-oriented interventions, are potentially useful in acute psychiatric hospitalizations, since they can be delivered as group therapies and are be both cost-effective and scalable. However, such interventions have rarely been provided to patients during psychiatric hospitalizations, where patients are treated for a variety of psychiatric diagnoses, and may have unpredictable lengths of stay. Additionally, there had been concerns that longer traditional mindfulness based interventions (e.g. 30 minute silent meditation) may exacerbate acute psychosis. However, strong evidence suggests that patients with psychotic symptoms appear to be largely unaffected by shorter interventions. Similarly, MBCT have been helpful to treat other major reasons for hospitalization such as: bipolar disorder, severe anxiety, substance use disorders, and major depressive disorder.

Few studies have examined mindfulness-oriented treatments in inpatient settings, including two small studies involving mindfulness groups on an acute psychiatric inpatient ward (n<10) . Another study (n=23) offered inpatients with a diagnosis of major depressive disorder mindfulness-based activities. All studies concluded that mindfulness-oriented approaches in inpatient settings were feasible, although these needed to be brief interventions, given the risks and lack of efficacy of longer MBI (e.g. 40-minute silent meditation) in severe mental illness.

A cross-sectional study conducted by our team (n=40) demonstrated that brief group mindfulness-oriented lasting 10 minutes were very well tolerated by 92.5% of psychiatric inpatients. The remaining 7.5% of patients left the session before 10-minutes, but had no symptomatic exacerbations or adverse effects. Moreover, the 50% of patients self- reported improvements in general well-being and mood after a single 10-minute session. Having been recently admitted to the psychiatric inpatient or having a diagnosis of acute psychosis (75% of inpatients) did not affect patients' capacity to tolerate and benefit from the intervention. In this inpatient psychiatric population, we found that mindfulness-oriented interventions that were brief and involved physical movement (e.g. seated Tai Chi) were better enjoyed compared to other interventions.

Despite the growing literature in this field, data is needed on the effectiveness and health service implications of brief group mindfulness-oriented interventions in inpatient psychiatry settings. Outcome studies conducted so far cannot be interpreted reliably due to methodological flaws, including inadequate control groups, very small sample sizes (often n<10), and lack of randomization. In Canada, the direct cost of treatment for mental illness is estimated as 42.3 billion. Much of these costs are driven by psychiatric admissions. Thus, if brief mindfulness-oriented interventions are effective at lowering psychiatric symptom severity and shortening psychiatric hospitalizations, this could lead to significant cost-savings.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02987426
Study type Interventional
Source Lady Davis Institute
Contact
Status Completed
Phase Phase 2/Phase 3
Start date May 19, 2017
Completion date February 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT00166764 - A Study on Evaluation of Mental Health Index of Patients With Psychiatric Disorders N/A
Recruiting NCT06062953 - Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia Phase 2/Phase 3
Recruiting NCT05548946 - A Dimensional Model for Personality Disorders in Later Life N/A
Completed NCT03313154 - Impact on QoL and Cognitive Functioning of New Antiviral Therapies in Subjects With Chronic Hepatitis HCV-related
Completed NCT00783783 - CYP2D6 Pharmacogenetics in Risperidone-Treated Children N/A
Completed NCT01989728 - Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness Absence N/A
Completed NCT03125083 - Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus N/A
Recruiting NCT01066299 - Influence of Oxytocin on the Startle Reflex and on Its Modulation N/A
Recruiting NCT05784818 - Up To Me: Erasing the Stigma of Mental Illness on College Campuses N/A
Completed NCT01786733 - Behavioral Activation - From Inpatient to Outpatient Services N/A
Withdrawn NCT03907124 - Clinical Utility of Pharmacogenomics of Psychotropic Medications Phase 4
Withdrawn NCT03809897 - Varenicline for Smoking Cessation in Hospitalized Patients With Psychiatric Disorders Phase 4
Not yet recruiting NCT02857322 - Effectiveness Accompaniment Perioperative Patients With Psychiatric Illness on the Lives Perioperative N/A
Terminated NCT02665988 - Adjunctive Transcranial Direct Current Stimulation N/A
Completed NCT01289080 - Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects Phase 1
Completed NCT01823250 - Culturally Informed Family Based Treatment of Adolescents: A Randomized Trial Phase 2
Active, not recruiting NCT00982943 - The Epidemiological Study on Psychiatric Disorders and Psychotropic Drugs N/A
Completed NCT00184340 - Secured Internet-mediated Psychotherapy With Psychiatry Patients N/A
Completed NCT00184327 - Changes Following Inpatient Child-oriented Family Treatment Phase 1
Recruiting NCT04381845 - Immunity and Infections in the Psychiatric Population N/A